Pulmonx (LUNG) Depreciation & Amortization (CF) (2019 - 2025)
Pulmonx (LUNG) reported Depreciation & Amortization (CF) of $246000.0 for Q3 2025, down 34.57% year-over-year from $376000.0 in Q3 2024, and down 17.73% on a QoQ basis from $299000.0 in Q2 2025.
Pulmonx (LUNG) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $246000.0 in Q3 2025.
- Quarterly Depreciation & Amortization (CF) fell 34.57% year-over-year to $246000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $823000.0 (down 44.88% YoY) and the FY2024 annual result came in at $1.5 million, down 3.55% from the prior year.
- Depreciation & Amortization (CF) retreated to $246000.0 in Q3 2025 per LUNG's latest filing, from $299000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $437000.0 in Q1 2023 and bottomed at $141000.0 in Q1 2021.
- The 5-year median for Depreciation & Amortization (CF) is $374000.0 (2021), against an average of $328631.6.
- The widest annual swing landed in 2021, when Depreciation & Amortization (CF) surged 192.19%; it then plunged 34.57% in 2025.
- Tracing LUNG's Depreciation & Amortization (CF) over 5 years: stood at $374000.0 in 2021, then rose by 3.21% to $386000.0 in 2022, then decreased by 25.65% to $287000.0 in 2023, then advanced by 2.44% to $294000.0 in 2024, then decreased by 16.33% to $246000.0 in 2025.
- Per Business Quant, the three latest LUNG Depreciation & Amortization (CF) figures stand at $246000.0 (Q3 2025), $299000.0 (Q2 2025), and $278000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 246,000.00 |
| Sep 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Sep 30, 2024 | 376,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 415,000.00 |
| Sep 30, 2023 | 415,000.00 |
| Jun 30, 2023 | 409,000.00 |
| Jun 30, 2023 | 409,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 386,000.00 |
| Dec 31, 2022 | 386,000.00 |
| Sep 30, 2022 | 383,000.00 |
| Sep 30, 2022 | 383,000.00 |
| Jun 30, 2022 | 376,000.00 |
| Jun 30, 2022 | 376,000.00 |
| Mar 31, 2022 | 368,000.00 |
| Mar 31, 2022 | 368,000.00 |
| Dec 31, 2021 | 374,000.00 |
| Dec 31, 2021 | 374,000.00 |
| Sep 30, 2021 | 206,000.00 |
| Sep 30, 2021 | 206,000.00 |
| Jun 30, 2021 | 146,000.00 |
| Jun 30, 2021 | 146,000.00 |
| Mar 31, 2021 | 141,000.00 |
| Mar 31, 2021 | 141,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Dec 31, 2020 | 128,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 117,000.00 |
| Jun 30, 2020 | 117,000.00 |
| Mar 31, 2020 | 116,000.00 |
| Mar 31, 2020 | 116,000.00 |
| Dec 31, 2019 | 112,000.00 |
| Dec 31, 2019 | 112,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |